Enliang Li Selected Research

Antigens

4/2019	A novel prognostic model for diagnosing atypical bile duct hyperplasia in patients with intrahepatic lithiasis.
9/2017	Overexpression of non‑SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enliang Li Research Topics

Disease

16	Neoplasms (Cancer) 12/2023 - 09/2017
8	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 07/2017
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2021
2	Liver Neoplasms (Liver Cancer) 01/2021 - 01/2020
2	Carcinogenesis 01/2020 - 12/2018
2	Neoplasm Metastasis (Metastasis) 01/2020 - 08/2018
1	Klatskin Tumor 04/2024
1	Liver Failure 04/2024
1	Primitive Neuroectodermal Tumors (PNET) 01/2023
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2022
1	Hepatitis 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Hyperplasia 04/2019
1	Lithiasis 04/2019
1	Circulating Neoplastic Cells 07/2017
1	Pathologic Constriction (Stenosis) 02/2017

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2022 - 09/2017
3	MicroRNAs (MicroRNA)IBA 10/2022 - 12/2018
3	Phosphotransferases (Kinase)IBA 09/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2017
2	Proto-Oncogene Proteins c-metIBA 01/2020 - 01/2020
2	AntigensIBA 04/2019 - 09/2017
2	InterferonsIBA 12/2018 - 08/2018
1	BismuthIBA 04/2024
1	cyclo(Arg-Pro) (CI 4)IBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 12/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	KinesinsIBA 10/2022
1	Minichromosome Maintenance Complex Component 2IBA 01/2022
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 01/2022
1	Collagenases (Collagenase)FDA Link 11/2021
1	tyrosine receptor (receptor, tyrosine)IBA 09/2021
1	Immune Checkpoint InhibitorsIBA 09/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 09/2021
1	B7-H1 AntigenIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	5-ethynyl-2'-deoxyuridineIBA 01/2021
1	Competitive Endogenous RNAIBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	VaccinesIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Adenosine Triphosphatases (ATPase)IBA 01/2020
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Circular RNAIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	CarbohydratesIBA 04/2019
1	p38 Mitogen-Activated Protein KinasesIBA 08/2018
1	ChromatinIBA 09/2017

Therapy/Procedure

4	Immunotherapy 10/2023 - 01/2020
3	Therapeutics 12/2023 - 01/2020
1	Hepatectomy 04/2024
1	Molecular Targeted Therapy 01/2022
1	Cholecystectomy 01/2022
1	Subcutaneous Injections 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Liver Transplantation 01/2020
1	Stents 02/2017